Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
The diagnosis of intravascular catheter-related infections continues to be a challenge to both the clinician and the microbiologist. To assess the antiseptic effects of silver-sulfadiazine-chlorhexidine-impregnated central venous catheters (SSC) on catheter culture systems, segments of fresh antiseptic- and non antiseptic-impregnated catheters as well as extracted catheters following five days of immersion in PBS were sonicated. The chlorhexidine liberated from the catheter material by ultrasonication was measured by HPLC. Fresh antiseptic-impregnated catheter segments rolled on seeded agar plates produced inhibition zones unlike catheters which had been extracted for >five days in phosphate buffered saline (PBS). Scanning electron microscopy (SEM) revealed that chlorhexidine-silversulfadiazine crystals were located in the superficial catheter matrix. Direct contact of superficially located drug particles with seeded agar plates probably caused the inhibition of bacterial growth. The study suggests that antiseptic compounds readily elute from fresh catheters during solid medium-based culturing processes and ultrasonication. The addition of inhibitors of silversulfadiazine-chlorhexidine to media may be prudent especially when culturing antimicrobial loaded catheters removed after short inwelling times.
Schierholz
J M
JM
Institute of Medical Microbiology and Hygiene, University of Cologne, Goldenfelsstr. 19-21, 50935 Cologne, Germany.
Bach
A
A
Fleck
C
C
Beuth
J
J
König
D
D
Pulverer
G
G
D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002710:Chlorhexidine / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D015169:Colony Count, Microbial / Q000379:methods*; D003428:Cross Infection / Q000175:diagnosis* / Q000209:etiology; D004338:Drug Combinations; D006801:Humans; D066298:In Vitro Techniques; D008855:Microscopy, Electron, Scanning; D012837:Silver Sulfadiazine / Q000494:pharmacology*; D014465:Ultrasonics
D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D002710:Chlorhexidine; D012837:Silver Sulfadiazine